Design Therapeutics
Arsani William, M.D. has served as a member of our board of directors since January 2021. Dr. William has served as Managing Partner and Chief Investment Officer of Logos Capital since its founding in 2019. Prior to founding Logos, Dr. Williams served as an investment professional at Farallon Capital Management. Dr. Williams holds an M.D. from Harvard Medical School where he was a Gerald S. Foster Scholar, an MBA from Stanford’s Graduate School of Business, and a BS with Honors in Biology from Stanford University.
This person is not in the org chart
This person is not in any offices
Design Therapeutics
1 followers
Design Therapeutics is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs™), designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.